Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
1,090
-
Total 13F shares, excl. options
-
144,371,093
-
Shares change
-
-6,623,647
-
Total reported value, excl. options
-
$45,633,042,157
-
Value change
-
-$2,072,462,238
-
Put/Call ratio
-
127%
-
Number of buys
-
415
-
Number of sells
-
-572
-
Price
-
$316.38
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q1 2020
1,263 filings reported holding BIIB - BIOGEN INC. - COM as of Q1 2020.
BIOGEN INC. - COM (BIIB) has 1,090 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 144,371,093 shares
of 146,614,676 outstanding shares and own 98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16,043,035 shares), PRIMECAP MANAGEMENT CO/CA/ (15,965,989 shares), VANGUARD GROUP INC (14,238,227 shares), STATE STREET CORP (8,262,242 shares), RENAISSANCE TECHNOLOGIES LLC (4,473,912 shares), Clearbridge Investments, LLC (4,407,311 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,284,557 shares), WELLINGTON MANAGEMENT GROUP LLP (4,095,239 shares), GEODE CAPITAL MANAGEMENT, LLC (3,372,294 shares), and NORTHERN TRUST CORP (2,470,802 shares).
This table shows the top 1,090 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.